{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:02:59Z","timestamp":1768870979386,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cyto.2020.155172","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T22:56:05Z","timestamp":1592952965000},"page":"155172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["IFN-\u03b1-2b induces apoptosis by decreasing cellular cholesterol levels in rat preneoplastic hepatocytes"],"prefix":"10.1016","volume":"133","author":[{"given":"Ariel D.","family":"Quiroga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina C.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabela C.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla G.","family":"Comanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Lambertucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda P.","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda C.","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155172_b0005","article-title":"Biologic activities of natural and synthetic type I interferons","volume":"24","author":"Pfeffer","year":"1997","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.cyto.2020.155172_b0010","first-page":"883","article-title":"The differential effects of three forms of interferon alfa on hepatic regeneration after partial hepatectomy in the rat","volume":"22","author":"Wong","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2020.155172_b0015","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2020.155172_b0020","doi-asserted-by":"crossref","first-page":"20047","DOI":"10.1074\/jbc.R700004200","article-title":"The interferons: 50 years after their discovery, there is much more to learn","volume":"282","author":"Pestka","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2020.155172_b0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1521-6926(02)00084-1","article-title":"Interferon in the treatment of hairy-cell leukemia","volume":"16","author":"Ahmed","year":"2003","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.cyto.2020.155172_b0030","article-title":"Evaluation of the effect of topical interferon alpha2b as a complementary treatment of macular edema of patients with diabetic retinopathy: a double-blind placebo-controlled randomized clinical trial study","author":"Afarid","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.cyto.2020.155172_b0035","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.4049\/jimmunol.1290060","article-title":"IFN-alpha in the treatment of melanoma","volume":"189","author":"Tarhini","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155172_b0040","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.21037\/atm.2019.04.57","article-title":"Pembrolizumab plus ipilimumab or pegylated interferon alfa-2b for patients with melanoma or renal cell carcinoma: take new drugs but keep the old?","volume":"7","author":"Zibelman","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cyto.2020.155172_b0045","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/14740338.2017.1343301","article-title":"The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanoma","volume":"16","author":"Trinh","year":"2017","journal-title":"Exp. Opin. Drug Saf."},{"key":"10.1016\/j.cyto.2020.155172_b0050","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1200\/JCO.2009.26.7849","article-title":"Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival","volume":"28","author":"Escudier","year":"2010","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.cyto.2020.155172_b0055","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2009.26.5561","article-title":"Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206","volume":"28","author":"Rini","year":"2010","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.cyto.2020.155172_b0060","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1038\/s41598-019-47074-y","article-title":"Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection","volume":"9","author":"Gull","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2020.155172_b0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-981-13-9151-4_6","article-title":"Present and future therapies for chronic hepatitis B","volume":"1179","author":"Tao","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cyto.2020.155172_b0070","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/jhep.2002.32099","article-title":"The in vivo apoptotic effect of interferon alfa-2b on rat preneoplastic liver involves Bax protein","volume":"35","author":"de Lujan","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2020.155172_b0075","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bcp.2007.02.007","article-title":"Involvement of reactive oxygen species on the apoptotic mechanism induced by IFN-alpha2b in rat preneoplastic liver","volume":"73","author":"Quiroga","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cyto.2020.155172_b0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.20307","article-title":"Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1)","volume":"40","author":"de Lujan","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2020.155172_b0085","doi-asserted-by":"crossref","first-page":"114650","DOI":"10.1016\/j.taap.2019.114650","article-title":"IFN-alpha-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice","volume":"379","author":"Quiroga","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cyto.2020.155172_b0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mnfr.201300362","article-title":"Quercetin prevents liver carcinogenesis by inducing cell cycle arrest, decreasing cell proliferation and enhancing apoptosis","volume":"58","author":"Casella","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.cyto.2020.155172_b0095","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/liv.12421","article-title":"FoxO3a modulation and promotion of apoptosis by interferon-alpha2b in rat preneoplastic liver","volume":"34","author":"Parody","year":"2014","journal-title":"Liver Int.: Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.cyto.2020.155172_b0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nut.2018.08.016","article-title":"Vitamin K2 supplementation blocks the beneficial effects of IFN-alpha-2b administered on the early stages of liver cancer development in rats","volume":"59","author":"Vera","year":"2019","journal-title":"Nutrition."},{"key":"10.1016\/j.cyto.2020.155172_b0105","unstructured":"W. Strober, Trypan blue exclusion test of cell viability. Current protocols in immunology, Appendix 3:Appendix 3B, 2001."},{"key":"10.1016\/j.cyto.2020.155172_b0110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0022-2275(20)32118-0","article-title":"Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36","volume":"40","author":"Han","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cyto.2020.155172_b0115","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/0008-5472.CAN-07-6161","article-title":"Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma","volume":"68","author":"Montero","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2020.155172_b0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-408051-5.00007-3","article-title":"Analysis of lipid droplets in hepatocytes","volume":"116","author":"Wang","year":"2013","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.cyto.2020.155172_b0125","first-page":"2043","article-title":"Hepatic carboxylesterase 3 (Ces3\/Tgh) is downregulated in the early stages of liver cancer development in the rat","volume":"1862","author":"Quiroga","year":"2016","journal-title":"BBA"},{"key":"10.1016\/j.cyto.2020.155172_b0130","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.25961","article-title":"Deficiency of carboxylesterase 1\/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia","volume":"56","author":"Quiroga","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2020.155172_b0135","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cyto.2020.155172_b0140","doi-asserted-by":"crossref","first-page":"17815","DOI":"10.18632\/oncotarget.7404","article-title":"AMPK and PKA interaction in the regulation of survival of liver cancer cells subjected to glucose starvation","volume":"7","author":"Ferretti","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.cyto.2020.155172_b0145","first-page":"S9-4-S9-17","article-title":"The human interferon-alpha species and hybrid proteins","volume":"24","author":"Pestka","year":"1997","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.cyto.2020.155172_b0150","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.510250632","article-title":"Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C","volume":"25","author":"Shinohara","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2020.155172_b0155","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2036.2000.00792.x","article-title":"Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C","volume":"14","author":"Andrade","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.cyto.2020.155172_b0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2020.155172_b0165","doi-asserted-by":"crossref","first-page":"e1000598","DOI":"10.1371\/journal.pbio.1000598","article-title":"Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis","volume":"9","author":"Blanc","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cyto.2020.155172_b0170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3389\/fimmu.2016.00634","article-title":"Interferon control of the sterol metabolic network: bidirectional molecular circuitry-mediating host protection","volume":"7","author":"Robertson","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2020.155172_b0175","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1073\/pnas.91.4.1198","article-title":"Cytokine therapeutics: lessons from interferon alpha","volume":"91","author":"Gutterman","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.cyto.2020.155172_b0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis","volume":"4","author":"Mari","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.cyto.2020.155172_b0185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tem.2011.03.003","article-title":"Role of endoplasmic reticulum neutral lipid hydrolases","volume":"22","author":"Quiroga","year":"2011","journal-title":"Trends Endocrinol. Metab.: TEM."},{"key":"10.1016\/j.cyto.2020.155172_b0190","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.ATV.12.9.1053","article-title":"The effect of interferon on the metabolism of LDLs","volume":"12","author":"Schectman","year":"1992","journal-title":"Arteriosclerosis Thrombosis J. Vasc. Biol."},{"key":"10.1016\/j.cyto.2020.155172_b0195","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/j.1572-0241.1998.00546.x","article-title":"Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha","volume":"93","author":"Fernandez-Miranda","year":"1998","journal-title":"Am. J. Gastroenterol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620301885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620301885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:43Z","timestamp":1760907583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620301885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"alternative-id":["S1043466620301885"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155172","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN-\u03b1-2b induces apoptosis by decreasing cellular cholesterol levels in rat preneoplastic hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155172"}}